Tu1254: SARS-COV-2 VACCINATION HESITANCY AND RISK OF DISEASE FLARE ARE BOTH LOW AMONG AN AUTOIMMUNE HEPATITIS PATIENT COHORT

Detalles Bibliográficos
Autores principales: Chalasani, Sai, Guardiola, John, Lammert, Craig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AGA Institute. Published by Elsevier Inc. 2022
Materias:
AASLD Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212641/
http://dx.doi.org/10.1016/S0016-5085(22)63675-8
_version_ 1784730648330633216
author Chalasani, Sai
Guardiola, John
Lammert, Craig
author_facet Chalasani, Sai
Guardiola, John
Lammert, Craig
author_sort Chalasani, Sai
collection PubMed
description
format Online
Article
Text
id pubmed-9212641
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AGA Institute. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92126412022-06-22 Tu1254: SARS-COV-2 VACCINATION HESITANCY AND RISK OF DISEASE FLARE ARE BOTH LOW AMONG AN AUTOIMMUNE HEPATITIS PATIENT COHORT Chalasani, Sai Guardiola, John Lammert, Craig Gastroenterology AASLD Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212641/ http://dx.doi.org/10.1016/S0016-5085(22)63675-8 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle AASLD Abstracts
Chalasani, Sai
Guardiola, John
Lammert, Craig
Tu1254: SARS-COV-2 VACCINATION HESITANCY AND RISK OF DISEASE FLARE ARE BOTH LOW AMONG AN AUTOIMMUNE HEPATITIS PATIENT COHORT
title Tu1254: SARS-COV-2 VACCINATION HESITANCY AND RISK OF DISEASE FLARE ARE BOTH LOW AMONG AN AUTOIMMUNE HEPATITIS PATIENT COHORT
title_full Tu1254: SARS-COV-2 VACCINATION HESITANCY AND RISK OF DISEASE FLARE ARE BOTH LOW AMONG AN AUTOIMMUNE HEPATITIS PATIENT COHORT
title_fullStr Tu1254: SARS-COV-2 VACCINATION HESITANCY AND RISK OF DISEASE FLARE ARE BOTH LOW AMONG AN AUTOIMMUNE HEPATITIS PATIENT COHORT
title_full_unstemmed Tu1254: SARS-COV-2 VACCINATION HESITANCY AND RISK OF DISEASE FLARE ARE BOTH LOW AMONG AN AUTOIMMUNE HEPATITIS PATIENT COHORT
title_short Tu1254: SARS-COV-2 VACCINATION HESITANCY AND RISK OF DISEASE FLARE ARE BOTH LOW AMONG AN AUTOIMMUNE HEPATITIS PATIENT COHORT
title_sort tu1254: sars-cov-2 vaccination hesitancy and risk of disease flare are both low among an autoimmune hepatitis patient cohort
topic AASLD Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212641/
http://dx.doi.org/10.1016/S0016-5085(22)63675-8
work_keys_str_mv AT chalasanisai tu1254sarscov2vaccinationhesitancyandriskofdiseaseflarearebothlowamonganautoimmunehepatitispatientcohort
AT guardiolajohn tu1254sarscov2vaccinationhesitancyandriskofdiseaseflarearebothlowamonganautoimmunehepatitispatientcohort
AT lammertcraig tu1254sarscov2vaccinationhesitancyandriskofdiseaseflarearebothlowamonganautoimmunehepatitispatientcohort

Ejemplares similares